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Topical application of amiloride, a potent inhibitor 
of the Na + IH+ antiport, inhibits cutaneous inflam-
mation induced by ultraviolet radiation or contact 
hypersensitivity in mice . Arniloride analogues with 
greater and lesser inhibition of the Na+/H+ exchange 
were tested to determine whether anti-inflammatory 
effects correlate with this activity. Structural ana-
logues of amiloride without significant activity at the 
N a + IH+ antiport (pyrazine, pyrazinamide, and chlo-
r opyrazine) failed to inhibit contact hypersensitivity. 
N-amidino-3-amino-5-dirnethyl amino-6-chloropy-
razinecarboxarnide (DMA) has a 23-fold greater affin-
ity for the Na + IH + antiport compared to amiloride, 
but failed to inhibit contact hypersensitivity in this 
assay. 3,5-diamino-6-chloropyrazine-amido-guani-
A mil oride h ydrochloride is use d clinically as a potas-sium-sparing diuretic. Although its sp ecific m echa-nism of ac tion has n ot been elucidated, many studies h ave shown that amiIo ride inhibits ion transport, particularly at the N a + /H+ antiport [1-3]. Our 
laboratory demonstrated pre viously tha t topi cal application of 
amijoride inhibite d tissue inflammatio n caused by contac t hyper-
sensitiv ity (CHS) or ultraviolet radiation [4]. Amiloride also h as 
been shown to inhibit the re lease of severa l cytokines (inte rleu)ciJls-
1/3' -6, and -8; tumor n ecrosis facto r) by pulmonary macrophages 
[5]. T h e mechanism of action b y w hich a miloride inhibits inflam-
mation remains unkn own. Its effects m ay be due to tbe blockad e of 
ion transport and thus in tracellular signa ling [6 ,7], inhibition of cell 
proli feration [8-10J, or inhibitio n of protein syn thesis [11- 14] . This 
study inves tigated furth e r th e m ech anism(s) of amiloride action by 
using amiloride an alog ues. Structural analogues, as well as aJ1a-
log ues tha t are eith er more o r less potent for inhibiting the 
Na + /H + antiport [3,15,16], were examined for the a bility to 
inhibit CHS, penetrate murine skin, and affect protein synthesis. 
MA TERIALS AND METHODS 
Reagents Amiloride hydrochloride was purchased frOI11 Sigma C hemical 
Co. (St. Louis, MO). Pyrazinc. pyrazinamide, and chloropyrazine were 
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dine (DeG), which has only 7% of the affinity of 
amiloride for the antiport, suppressed contact hyper_ 
sensitivity as well as amiloride. Experiments examin_ 
ing the ability of these agents to diffuse through 
mouse skin revealed amiloride to be superior to both 
DeG and DMA, which were approximately equal. 
DMA, with greater inhibition of the Na + IH+ antiport 
but lesser ability to inhibit contact hypersensitivity, 
inhibited protein synthesis and induced cell death 
rnore than amiloride or DeG. Arniloride and DeG 
hold promise as topical anti-inflammatory agents. 
Their anti-inflammatory properties do not correlate 
with affinity for the Na + IH+ antiport, ability to pen-
etrate murine skin, or inhibition of protein synthesis. 
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purchased frOI11 Aldrich (Milwaukee, WI) . N-al11idino-3-amino-5-dimethyl 
amino-6-ch.loropyrazinecarboxam ide (DMA) and 3,5-diamino- 6-chloropy-
razine-al11ido-guanidine (DCG) werc the kind gifts of Shiseido Co. , Ltd. 
(Tokyo, Japan). The strucUlres of DMA and DCG were vcrificd by nuclcar 
magnetic resonance. The chemica l structures of these agents are shown in 
Fig 1. 
Animals Female mice of the strain C57BL16 , 6-8 weeks of age , were 
purchased from T he Jackson Laboratory (Bar Harbor, ME). O utbred Swiss 
athymic nude mice (nu/nu) were obtained frol11 the Radia tion Biology 
Laboratory at Massachusetts General H ospital. Mice were housed in a 
facility with a 12-h on/12-h off light setting and had ad /il>il.lIlII access to 
mou se chow and chlorinated water. 
CHS Reaction Mice were sensitized on their shaved abdol11ens with 20 
ILl of 2'Yo wtlvol 2,4,6-trinitrochlorobenzene (TN CB) (Eastman Kodak, 
H .. ochcster, NY) in a 4:1 solution of acetone and corn oil. Negative contro l 
animals received no abdominal coating . Elicitation was performed 5-7 d 
later by coa ting both dorsa l and ventral e"r surfaces with 5 ILl of 1 % TNCB 
in a 4: 1 solu tion of ace tone and corn oil. The 24-h car sweUing was 
measured in a coded f.1shion with a spring- loaded micrometer (Fowler, 
Biggsfield, England) . 
Ami loride and analogues were dissolved in distilled water before they 
were added to the proper weight of hydrated petro latul11 (Denison Phar-
maceuticals, Pawtucket, R1) . Chloropyrazinc, a liquid, was added directly 
to the hydrated petrolatum. At 1 h and t 2 h after elicitation of the CHS 
reaction, both surf.1ces of the e"rs were covered with a th.in layer of the 
indicated oin tment. The negative and positive controls received hydrated 
petrolatum alone. 
Five micc were assigncd to each group. The two-tailed Student t test for 
unpaired samples waS performed to determine the statistical signifi cance 
betwecn each group and the positive control. 
Protein Synthesis Assay The murine transformed keratinocyte cell line 
PAM 212 was ma.intaincd in R1)Ml-1.640 with addition of 1 mM sodium 
pyruvate, 10 mM Hepes buffer, 0.1 111M essen tia l and 0.1 mM nonessential 
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Figure L AtniIoride and analogue structures. Comparison of the 
structures of the pyrazinc ring, the amide of the pyrazine ring, and a 
chlo rinated pyrazine ring with amilo ride, D MA, and DCG. 
amino acids, 2 111M L-glutamine, 100 U / ml pcnicillin , '100 !J.g/ ml strep to-
mycin , and 10% heat-inactivated feta l bovin e serum (Gibco Labo ratori es, 
Grand Island, NY) . Cells we re grown in tissue culture at 37°C in a SIX, CO, 
humidifi ed incubato r. Cells were washed and plated in 96- well ro und: 
bottom plates at a concentratio n o f 5 X 10.1 cells/well . Twenty-fo ur ho urs 
later, while the cells were still subconAuent, the m edium was removed and 
new m edium added w ith indicated additions. Emetine, a potent inhibitor of 
prote in synthes is [1 7J, was added to parall el cell cul tul'es to inhibit protein 
syn thesis as a contro l. Cells were cul tured for an additional J 8 h and then 
labeled with ' H-Ie ucine for 6 h. Wells were harvested with a semiau to-
mated cell harvester. ;l11d r;ldioactivity was assayed by liquid scintillation 
coun ti ng. Coun ts per minute were normalized to cell number. Cell s fio m 
parallel cul tures were used for cell coun ting . All groups were done in 
triplica te. 
Skin Penetration The subcuta neo us fat was removed m echanjcall y I]-o m 
the do rsa l skin of nude mice and placed between dual glass diffusio n 
chambers. Solutio ns of amiloride o r analogues in I mM Du lbecco's 
phosphate-buffered saline (Gibco) were placed in the epidennal-side cham-
ber, and phospha te-buffe red saline alone was placed o n the dermal side. T he 
glass chambers then were placed in a 3JOC water bath. At the times 
indicated , diffusion of the test substance thro ugh the dennis was measured 
by a spectroAuorimeter. T he Auorescence m easured was compared to 
standard concentration curves for each so lutio n prepared simultaneously. 
Emissio n scans dctcnnill cd 111:1xinll11l1 exc itation at the <wave length 370 I11H , 
which was used for each experiment. 
RESULTS 
Inhibition of CHS To ascerta in w h eth e r the activity of amjjo-
ride in inhibiting sodium-proton exch an ge con'elates with anti-
inflammatory activity, we examine d amiloride and two of its 
an a logues, with diffe re nt potency in inhibitio n of th e sodium-
proton antiport, for their anti-inflammatory activity in the CHS 
assay. Table I compares the inhjbito r y activ ity of the N a + / H + 
a.11tiport. One of these, DMA, has '1 23-fold g re ate r ability to inhibit 
the sodium-proton antiport compare d to the parent compo und 
[3,15,1 6) . The oth e r , DCG, h as o nly 7'Yu of the inhibito ry ac tivity of 
amjloride for the antipo rt (3) . As shown by the data in Fig 2 , DMA 
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Table I. Comparison of Amiloride and Analogues in 
Inhibition of Amiloride-Sensitive 22Na + Flux by Cultures 
of Chick Skeletal Muscle Cells 
AmilOlide/ 
Analogue 
DMA 
Ami lorid" 
DCG 
Concentratio n in !J.M 
Necessary to Inhibit 
Na + Flux by 50%" 
0.3 
7 
100 
II Froll! Vigne P. Frelin C, Cragoc EJ. Lazdllll~ki M: Structure-a ctivity rel::ltiollships 
of allliloridc :md ce rtain of its analogues in relation to the blockade of the Na + 11-1 + 
exchallge SYS i"C IIl . Mol Plinmlll(o/ 25: 13 1-1 36. 1984 13]. 
fa iled to inlubit the CHS response compared to the positive control 
at any concentration used. However, DCG produced potent inlu-
bition of the resp o nse in th e same con centration range as ami loride. 
Indeed, in m any experiments, a g reater inhibi tio n of th e response 
was o b served at low con centratio n s of DCG compared to equi va-
le nt con centratio ns of amilOl·ide (data n ot sh own ). 
Because the activity of th ese agents at the sodium-proton antiport 
d oes n ot appear to corre late with th e ab ility to inhibit the e licitation 
of CHS, oth er structural ana logues of ami loride, which do n ot have 
activity at th e sodium-proto n an tipo rt, a lso were exa mined for their 
ability to inhibit C HS. T hree compounds were tested, representing 
th e base pyrazine ring (pyrazine), th e amide of the base pyrazine 
(pyrazinamide), and a c hlorina ted py razin e ring (ch loropyrazin e). 
As sh own in Fig 3, none of these compollnds had inhibitory activity 
at th e con centratio ns tested. 
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Figure 2 . Inhibition of the Na + IH+ antiport docs no t correlate with 
inhibition of CHS. Mice were sensitized to TNCB and 5- 7 d later 
challenged with 5 !J.l of 1% TNCB to bo th dorsal and ven tra l car surf.1ces. 
At 1 h and "1 2 h later. both car surfaces were cO:lted with a th in layer of the 
indicated o intnlCll t at different wt/ ,vt concentrations. and CHS 'was as-
sessed . DMA (closed rircles) was unable to inhibit the C HS response at an)' 
concentration. DCG (closed .I"'IIIlIres) sign ificantly sup pressed CHS in a 
dose-dependent fas hion fi'om 0.5% to 2% wt/ wt (2%. p < 0.001; 1 %. p = 
0.017; 0.5%. P < 0.001; 0.1 %, P = 7.33) Amiloride (opm 5'1"l1n'S) also 
inhibi ted the C HS response at 0.5%, to 2% (2%. P = 0.001; 1%. p = 0.002; 
0.5%. P = 0.023; 0. 1%, p = 0.945) . T hese data represent o ne of fo ur 
experiments performed. n = 5 for all groups. except for 2% :Imiloride and 
0. 1 % DMA, for w hjch n = 4. Data points represent the mean ± standard 
erro r of the 11lc an. 
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Figure 3. Structural analogues of amiloride do not inhibit CHS. At 
1 h and 12 h after e licitation ofCHS to 1 % T N CB, amiloridc and 3miloride 
analogue oin tments were ap plied as dcscribed in Materials alld Methods, and 
C HS was assessed. T he base ring pyrazine (closed tr;allgles) failed to inhibit 
CHS at any concentration. Pyrazinamide (opell circles) and chloropyrazine 
(closed circles) were unable to inhibit C HS. Amiloride (opell sqllares) signifi-
cantl y inhibited CH S at aU concentrations (2%, p < 0.001; 1 %, p < 0.001; 
0. 1 %, p = 0.004). Data points reprcsent the mcan :!: standard error of the 
nlean. 
Penetration of Murine Skin To examine the possibility that 
the discrepancy in the activities of DMA and DCG for the 
sodium-proton antiport and the relative potencies of th ese agents in 
inhibiting CHS could be due to differences in the ability of these 
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F igure 4. Transit ofamiloride and analogues through murine skin. 
Onc-millimolar solutions of amiloridc (o/Jell St}"nrcs) , DMA (closed circles) . 
and DCG (apell tr;allgles) in Dulbecco's phospha tc-buffe red sa li ne we rc 
p laced on the epidennal side of dua l glass diffusion chambcrs. Diffusion 
through the dermis was measurcd by a specrroAuorimcter at the times 
indicatcd. T lus cxperiment represents onc of fo ur cxpcrimcJlts pcrformcd. 
Emission scans detcrmined maximum excitation at the wavelength 370 nm, 
wluch was used for all cxperimcnts. Conccntration curvcS for each compound 
were donc simultaneously. 
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F igure 5. The effect of al11iloride and analogues on protein syn-
thesis . PAM 212 cells were plated in a 96-well Aat-bottom plate . After 24 
h incubation, the culture mcdium was changed [0 medium containing 
amiJoride (opell sqllares) or the analogue. DMA (closed cinles) or DCG (closed 
sqllares). Cells wcre cul turcd further for 18 h and labeled with ' H-Icucine for 
6 h. Cell s from parallel cultu res were used for cell coun ting. This 
experim ent reprcscnts one of two expcrim ents pcrformed. ' I-I-Ieucine 
incorporation = 18,861 cpm in untrea ted cell s and 273 cpm in cells treated 
with 3.6 X 10- 2 mM emetine as a control for maximal inhibition of protein 
syn thes is. 
agents to penetrate murine skin, we designed experiments to assess 
directly transcutaneous movement of these compou nds. As shown 
by the data in Fig 4, amiloride was found to diffuse through mul'ine 
skin more rapidly then DMA or DCG. DMA and DCG penetrated 
with approximately equal facili ty. Of interest, the lesser penetration 
ofDCG contrasted with its equ al or better CHS-inhibitory activity 
compared with amiloride. Because DMA and DCG penetrated the 
skin with approxim ately equal ability, the rel ative concentrations at 
putative sites of action would not be expected to be different. 
Therefore, ne ither diffe rences in activity at the sodium- proton 
antiport alone nor penetration abi li ty can explain the re la tive 
differences in anti-inAammatory activ ity observed for these com-
po unds. 
Inhibition of Protein or DNA Synthesis Ami loride is known 
to have activities other than inhibition of ion exchange. For 
example, amiloride inhibits both protein and DNA synthesis at 
some concentrations (10 -12]. We examin ed w hether the re lati ve 
abilities of am iloride, DMA, and DCG to inhibit protein or DNA 
synthesis correlated with anti-inAammato ry activ ity. With regard to 
effects on protein synthesis, DMA was the most potent agent in 
inhibitill g protein synthesis (Fig 5). Similarly, DMA was th e most 
poten t agent in inhibiting thymidine uptake by PAM 212 cells, 
w hereas amiloride and DCG were roughl y equivalent (data not 
shown). For aU agents tested, concentrations that inlubited protein 
synthesis also affected cell viabili ty as assessed by trypan blue 
excl usi on. D M A was more potent thall amiloride or DCG in 
inhibiting prote in synth esis and in indu cing cell dea th. However, 
despite the efticien cy of DCG in inhibiting CHS, D CG was much 
less potent than amiloride for inhibition of protein synthesis and for 
induction of cell death . As a whole, these data suggest that neither 
inhibition of prote in synthes is or DNA synthesis, nor effects on cell 
viability, account for the relative potencies of these agents in 
inhibiting inAamm <l tion . 
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DISCUSSION 
These experiments address the mechanism(s) of action of topical 
amiloride in inhibiting CHS. Affinity for the Na + IH + antiport 
failed to correlate with the ability to inhibit CHS. DMA, with a 
23-fold greater inhibitory activity than amiloride for the Na + IH + 
anti port, was unable to inhibit the CHS response. However, DCG, 
with only 7% of the activity of amiloride for the antiport, sinUlarly 
suppressed CHS. This suggests that inhibition of the Na + IH+ 
antiport activity does not playa crucial role in the inhibition ofCHS 
observed with these agents . 
The abilities of amiloride, DCG, and DMA to inhibit protein 
synthesis and to induce cell death did not correlate with anti-in-
fl amma tory activity. Similarly, dilferences in the ability of these 
compounds to penetrate murine skin do not explain the relative 
anti-inRanU11atory activities observed. 
These ill "itro results, although important, must be interpreted 
appropriately. Although the elfects of amiloride on N a + IH+ 
exchange and on protein synthesis are not thought to be cell-type-
specific, the actual relevant targets of anUloride and its analogues in 
"i"o remain unclear, as do the concentrations over time of these 
agents at putative relevant sites ;'1 "i"o. 
Clearly, both topical amiloride and its analogue DCG have 
promise as elfective topical anti-inflammatory agents. Their precise 
mechanism(s) of action warrant further investigation. 
Special t1w"ks to Sileseido Co. for sy"tllesis of til e DMA ""d DCC col/lpo""ds ""d 
twe/enr mag"etic resolln"ce of their sfnlCtllres. 
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